Date of this Version
Although guidelines have recommended extended interval cervical screening using concurrent human papillomavirus (HPV) and cytology (“cotesting”) for over a decade, little is known about its adoption into routine care. Using longitudinal medical record data (2003-2015) from Kaiser Permanente Northern California (KPNC), which adopted triennial cotesting in 2003, we examined adherence to extended interval screening. We analyzed predictors of screening intervals among 504,202 women undergoing routine screening, categorizing interval length into early (
Rendle, Katharine A.; Schiffman, Mark; Cheung, Li C.; Kinney, Walter K.; Fetterman, Barbara; Poitras, Nancy E.; Lorey, Thomas; and Castle, Philip E., "Adherence Patterns to Extended Cervical Screening Intervals in Women Undergoing HPV and Cytology Cotesting" (2017). Departmental Papers (Family Medicine and Community Health). 1.
Date Posted: 22 August 2017